Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature
Balena, R., Hensley, I. E., Miller, S., Barnett, A. H.
Published in Diabetes, obesity & metabolism (01.06.2013)
Published in Diabetes, obesity & metabolism (01.06.2013)
Get full text
Journal Article
Taspoglutide, a once-weekly glucagon-like peptide1 analogue, vs. insulin glargine titrated to target in patients with Type2 diabetes: an open-label randomized trial
Nauck, M, Horton, E, Andjelkovic, M, Ampudia-Blasco, F. J, Parusel, C. T, Boldrin, M, Balena, R
Published in Diabetic medicine (01.01.2013)
Published in Diabetic medicine (01.01.2013)
Get full text
Journal Article
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)
Pratley, R. E., Urosevic, D., Boldrin, M., Balena, R.
Published in Diabetes, obesity & metabolism (01.03.2013)
Published in Diabetes, obesity & metabolism (01.03.2013)
Get full text
Journal Article
Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study
Ratner, R., Nauck, M., Kapitza, C., Asnaghi, V., Boldrin, M., Balena, R.
Published in Diabetic medicine (01.05.2010)
Published in Diabetic medicine (01.05.2010)
Get full text
Journal Article
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment
Gastaldelli, A., Balas, B., Ratner, R., Rosenstock, J., Charbonnel, B., Bolli, G. B., Boldrin, M., Balena, R.
Published in Diabetes, obesity & metabolism (01.02.2014)
Published in Diabetes, obesity & metabolism (01.02.2014)
Get full text
Journal Article
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial
Nauck, M., Horton, E., Andjelkovic, M., Ampudia-Blasco, F. J., Parusel, C. T., Boldrin, M., Balena, R.
Published in Diabetic medicine (01.01.2013)
Published in Diabetic medicine (01.01.2013)
Get full text
Journal Article
Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes
Kapitza, C., Heise, T., Birman, P., Jallet, K., Ramis, J., Balena, R.
Published in Diabetic medicine (01.11.2009)
Published in Diabetic medicine (01.11.2009)
Get full text
Journal Article
Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study
Delmas, P D, Balena, R, Confravreux, E, Hardouin, C, Hardy, P, Bremond, A
Published in Journal of clinical oncology (01.03.1997)
Published in Journal of clinical oncology (01.03.1997)
Get more information
Journal Article
Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G.A., Costantini, F.
Published in The EMBO journal (01.03.1994)
Published in The EMBO journal (01.03.1994)
Get full text
Journal Article
Safety and tolerability of high doses of taspoglutide, a once‐weekly human GLP‐1 analogue, in diabetic patients treated with metformin: a randomized double‐blind placebo‐controlled study1,2
Ratner, R., Nauck, M., Kapitza, C., Asnaghi, V., Boldrin, M., Balena, R.
Published in Diabetic medicine (01.05.2010)
Published in Diabetic medicine (01.05.2010)
Get full text
Journal Article
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
POLI, V, BALENA, R, FATTORI, E, MARKATOS, A, YAMAMOTO, M, TANAKA, H, CILIBERTO, G, RODAN, G. A, COSTANTINI, F
Published in The EMBO journal (01.03.1994)
Published in The EMBO journal (01.03.1994)
Get full text
Journal Article
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates
BELENA, R, TOOLAN, B. C, QUARTUCCIO, H, FIORAVANTI, C, CLAIR, J, BROWN, E, HAYES, W. C, RODAN, G. A, SHEA, M, MARKATOS, A, MYERS, E. R, LEE, S. C, OPAS, E. E, SEEDOR, J. G, KLEIN, H, FRANKENFIELD, D
Published in The Journal of clinical investigation (01.12.1993)
Published in The Journal of clinical investigation (01.12.1993)
Get full text
Journal Article
Prevention of early postmenopausal bone loss with cyclical etidronate therapy (A double-blind, placebo-controlled study and 1-year follow-up)
MEUNIER, P. J, CONFAVREUX, E, TUPINON, I, HARDOUIN, C, DELMAS, P. D, BALENA, R
Published in The journal of clinical endocrinology and metabolism (01.09.1997)
Published in The journal of clinical endocrinology and metabolism (01.09.1997)
Get full text
Journal Article
Differentiating between orchiectomized rats and controls using measurements of trabecular bone density: a comparison among DXA, histomorphometry, and peripheral quantitative computerized tomography
Rosen, H N, Tollin, S, Balena, R, Middlebrooks, V L, Beamer, W G, Donohue, L R, Rosen, C, Turner, A, Holick, M, Greenspan, S L
Published in Calcified tissue international (01.07.1995)
Published in Calcified tissue international (01.07.1995)
Get more information
Journal Article
Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone
BALENA, R, KLEEREKOPER, M, FOLDES, J. A, SHIH, M.-S, RAO, D. S, SCHOBER, H. C, PARFITT, A. M
Published in Osteoporosis international (01.08.1998)
Published in Osteoporosis international (01.08.1998)
Get full text
Journal Article
Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats
Lauritzen, D B, Balena, R, Shea, M, Seedor, J G, Markatos, A, Le, H M, Toolan, B C, Myers, E R, Rodan, G A, Hayes, W C
Published in Journal of bone and mineral research (01.07.1993)
Published in Journal of bone and mineral research (01.07.1993)
Get more information
Journal Article
Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae
Balena, R, Markatos, A, Seedor, J G, Gentile, M, Stark, C, Peter, C P, Rodan, G A
Published in The Journal of pharmacology and experimental therapeutics (01.01.1996)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.01.1996)
Journal Article
Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study
Fogelman, I, Herd, R J, Blake, G M, Balena, R
Published in Calcified tissue international (01.05.2000)
Published in Calcified tissue international (01.05.2000)
Get full text
Journal Article
Prevention of early postmenopausal bone loss with cyclical etidronate
ADAMI, S, BRUNI, V, BIANCHINI, D, BECORPI, A, LOMBARDI, P, CAMPAGNOLI, C, FERRARI, A, MARCHESONI, T, BALENA, R
Published in Journal of endocrinological investigation (01.05.2000)
Published in Journal of endocrinological investigation (01.05.2000)
Get full text
Journal Article